Abstract
Purpose
Due to the rarity of adenoid cystic carcinoma (ACC) of the major salivary gland, there is no consensus on the extent of prophylactic neck irradiation (PNI) for patients with clinically negative lymph nodes (cN0) disease.
Materials and methods
We conducted a retrospective analysis of all patients with ACC of the major salivary gland who received treatment at our center between January 2010 and April 2020. The primary endpoint was regional failure-free survival (RRFS). Secondary endpoints included overall survival (OS), distant metastasis-free survival (DMFS), local recurrence-free survival (LRFS), and acute toxicity.
Results
A total of 139 patients were included in the analysis. For cN0 patients, the 5-year RRFS, OS, DMFS, and LRFS were 93.2%, 90.2%, 75.7%, and 91.4%, respectively. Multivariate analysis revealed that PORT was an independent prognostic factor for RRFS and LRFS. No statistically significant differences were observed between the Level III sparing PNI group and the Standard PNI group in terms of RRFS, OS, DMFS, and LRFS. The doses delivered to the larynx and thyroid in the Level III sparing PNI group were significantly lower than those in the Standard PNI group.
Conclusion
In patients with cN0 ACC of the major salivary gland, PNI improves regional control, and the level III nodal region sparing radiotherapy does not increase the risk of level III recurrence, while potentially reducing toxicity.
Similar content being viewed by others
Data sharing statement
All relevant data were uploaded onto the Research Data Deposit public platform (www.researchdata.org.cn).
References
Hellquist H, Skalova A (2014) Histopathology of the salivary glands. Springer
Li N, Xu L, Zhao H et al (2012) A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer 118(16):3945–3953
Megwalu UC, Sirjani D (2017) Risk of nodal metastasis in major salivary gland adenoid cystic carcinoma. Otolaryngology-Head Neck Surg 156(4):660–664
National Comprehensive Cancer Network. Head and Neck Cancers (Version 1.2023).
Joshi NP, Broughman JR (2021) Postoperative management of salivary gland tumors. Curr Treat Options Oncol 22:1–10
Geiger JL, Ismaila N, Beadle B et al (2021) Management of salivary gland malignancy: ASCO guideline. J Clin Oncol 39(17):1909–1941
von der Grün J, Rödel C, Semrau S et al (2022) Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice. Strahlenther Onkol 198(2):123–134
Ning C, Zhao T, Wang Z et al (2018) Cervical lymph node metastases in salivary gland adenoid cystic carcinoma: a systematic review and meta-analysis. Cancer Manag Res 10:1677
Yuan J, Meng F, Xu C, et al (2022) Occult neck metastases risk factors and the role of elective neck dissection in cT3–4N0 adenoid cystic carcinoma of the parotid gland. Front Oncol 4696
Cox JD (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346
Amit M, Binenbaum Y, Sharma K et al (2015) Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma: an international collaborative study. Head Neck 37(7):1032–1037
Amit M, Na’ara S, Sharma K et al (2015) Elective neck dissection in patients with head and neck adenoid cystic carcinoma: an international collaborative study. Ann Surg Oncol 22:1353–1359
Qian ZJ, Chen MM, Divi V et al (2019) Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma. Head Neck 41(6):1903–1907
da Cruz PDE, de Abreu AF, Nishimoto IN et al (2006) Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 42(2):139–146
Gomez DR, Hoppe BS, Wolden SL, et al (2008) Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol* Biol* Phys 70(5):1365–1372
Al-Mamgani A, van Rooij P, Sewnaik A et al (2012) Adenoid cystic carcinoma of parotid gland treated with surgery and radiotherapy: long-term outcomes, QoL assessment and review of the literature. Oral Oncol 48(3):278–283
Shen C, Xu T, Huang C et al (2012) Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck. Oral Oncol 48(5):445–449
Kawakita D, Murase T, Ueda K et al (2020) The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan. Int J Clin Oncol 25:1774–1785
Chen AM, Garcia J, Lee NY, et al (2007) Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation?. Int J Radiat Oncol* Biol* Phys 67(4):988–994
Lee SY, Kim BH, Choi EC (2014) Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma. Head Neck 36(12):1796–1801
Balamucki CJ, Amdur RJ, Werning JW et al (2012) Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol 33(5):510–518
Bakhshandeh M, Hashemi B, Mahdavi SRM, et al (2013) Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol* Biol* Phys 85(2):514–521
Liu CH, Chang JTC, Lee TH et al (2021) Hypothyroidism and risks of cerebrovascular complications among patients with head and neck cancer after radiotherapy. BMC Neurol 21:1–8
Haggerty JJ Jr, Garbutt JC, Evans DL et al (1990) Subclinical hypothyroidism: a review of neuropsychiatric aspects. Int J Psychiatry Med 20(2):193–208
Sharabiani M, Clementel E, Andratschke N et al (2020) Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria. Radiother Oncol 146:143–150
Hutchison AR, Cartmill B, Wall LR et al (2019) Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: a systematized scoping review. Head Neck 41(6):2024–2033
Funding
The authors declare that they have no funding.
Author information
Authors and Affiliations
Contributions
ZQ YS: conception and design; ZQ XZ data collection; ZQ ZW: statistical analysis; ZQ ZW: manuscript preparation; YT YS: quality control of data and manuscript review; All authors read and approved the final manuscript. The name and email address of the author responsible for statistical analysis: Qiu Zichen: qiuzc@sysucc.org.cn.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval and consent to participate
This study was approved by the Medical Ethics Committee of Affiliated Hospital of Sun Yat-sen University Cancer Center with the approval number B2022-023-01, and the need for written informed consent was waived.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Qiu, Z., Wu, Z., Zhou, X. et al. Omission of radiotherapy to lymph node level III in patients with cN0 adenoid cystic carcinoma of the major salivary gland: a single center experience. Radiol med 129, 335–345 (2024). https://doi.org/10.1007/s11547-024-01763-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-024-01763-5